Filing Details

Accession Number:
0000899243-20-017758
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-26 16:15:21
Reporting Period:
2020-06-25
Accepted Time:
2020-06-26 16:15:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680581 Fulcrum Therapeutics Inc. FULC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577034 J Robert Gould C/O Fulcrum Therapeutics, Inc.
26 Landsdowne Street
Cambridge MA 02139
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-25 2,500 $20.80 537,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.32 to $21.26, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.